October 9 - 11, 2018
The Jerusalem International Convention Centre (ICC)
Abstract submission deadline: Wednesday, June 6
Advance registration deadline: Wednesday, June 6
Oct. 9-11, 2018The Jerusalem International Convention Centre (ICC)Jerusalem, Israel
Extended Abstract Submission Deadline: Wednesday, June 6, 2018Advance Registration Deadline: Wednesday, June 6, 2018
Conference CochairsRichard M. Marais, Cancer Research UK Manchester Institute, University of Manchester, Manchester, England (EACR)Eli Pikarsky, Hebrew University of Jerusalem, Jerusalem, Israel (ISCR)Robert A. Weinberg, MIT Whitehead Institute for Biomedical Research, Cambridge, Massachusetts (AACR)
Scientific Programme CommitteeAnton J.M. Berns, Netherlands Cancer Institute, Amsterdam, NetherlandsCarlos M. Caldas, Cancer Research UK Cambridge Institute, Cambridge, EnglandPhilip D. Greenberg, Fred Hutchinson Cancer Research Center, University of Washington, Seattle, WashingtonEdith A. Perez, Genentech, Inc., South San Francisco, CaliforniaAngel Porgador, Ben-Gurion University of the Negev, Beer-Sheva, IsraelVarda Rotter, Weizmann Institute of Science, Rehovot, Israel
Hosted by the European Association for Cancer Research (EACR), the American Association for Cancer Research (AACR) and the Israel Society for Cancer Research (ISCR), the EACR-AACR-ISCR Special Conference builds on the hugely successful preceding conferences, hosted by the Italian Cancer Society (SIC).
The content will span the journey of discovery from basic principles to translational breakthroughs. Together with our colleagues in the organizing committee we assembled a great list of world-class speakers discussing key areas in cancer research. Special sessions will focus on specific success stories (lung cancer, melanoma, DNA damage repair), featuring both basic and translational researchers.
The conference format is designed to bring together basic, translational and clinical researchers, as well as researchers working on the development of new targeted therapeutics. Leading experts will present the latest achievements of multidisciplinary research dealing with drug action and resistance and highlight challenges that require a concerted multidisciplinary effort. The program will comprise Keynote Lectures, Plenary Symposia and parallel Scientific Symposia, and includes many slots for proffered talks and poster presentations with ample time for discussion.